BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35324470)

  • 1. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses.
    Battisti F; Falini P; Gorini G; Sassoli de Bianchi P; Armaroli P; Giubilato P; Giorgi Rossi P; Zorzi M; Battagello J; Senore C; Zappa M; Mantellini P
    Ann Ist Super Sanita; 2022; 58(1):16-24. PubMed ID: 35324470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020.
    Giorgi Rossi P; Carrozzi G; Falini P; Sampaolo L; Gorini G; Zorzi M; Armaroli P; Senore C; Sassoli de Bianchi P; Masocco M; Zappa M; Battisti F; Mantellini P
    Elife; 2023 Feb; 12():. PubMed ID: 36734526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
    Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
    Elife; 2023 Jan; 12():. PubMed ID: 36695411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diffusion of screening programmes in Italy, year 2010].
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diffusion of screening programmes in Italy, year 2009.
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study.
    Wilson R; Quinn-Scoggins H; Moriarty Y; Hughes J; Goddard M; Cannings-John R; Whitelock V; Whitaker KL; Grozeva D; Townson J; Osborne K; Smits S; Robling M; Hepburn J; Moore G; Gjini A; Brain K; Waller J
    Prev Med; 2021 Dec; 153():106826. PubMed ID: 34599921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diffusion of screening programmes in Italy, years 2011-2012.
    Zappa M; Carozzi FM; Giordano L; Sassatelli R; Federici A; Zorzi M; Federici A
    Epidemiol Prev; 2015; 39(3 Suppl 1):5-8. PubMed ID: 26405771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
    Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
    Elife; 2023 Mar; 12():. PubMed ID: 36943035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of COVID-19 pandemic in the colorectal cancer prevention.
    Del Vecchio Blanco G; Calabrese E; Biancone L; Monteleone G; Paoluzi OA
    Int J Colorectal Dis; 2020 Oct; 35(10):1951-1954. PubMed ID: 32500432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.
    Ferrara G; De Vincentiis L; Ambrosini-Spaltro A; Barbareschi M; Bertolini V; Contato E; Crivelli F; Feyles E; Mariani MP; Morelli L; Orvieto E; Pacella E; Venturino E; Saragoni L
    Am J Clin Pathol; 2021 Jan; 155(1):64-68. PubMed ID: 32995855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.
    De Vincentiis L; Carr RA; Mariani MP; Ferrara G
    J Clin Pathol; 2021 Mar; 74(3):187-189. PubMed ID: 32561524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    Su CH; Hsu PS; Lin CS
    BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.